Are you Dr. Andrey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 86 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10666 N Torrey Pines Rd
La Jolla, CA 92037Phone+1 858-554-8632- Is this information wrong?
Summary
- Dr. Jeffrey Andrey, MD is an oncologist in La Jolla, California. He is currently licensed to practice medicine in California, Georgia, and Illinois. He is affiliated with Scripps Green Hospital, Scripps Memorial Hospital-La Jolla, and Naval Medical Center San Diego.
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997- Loyola University Medical CenterResidency, Internal Medicine, 1991 - 1994
Loyola University Chicago Stritch School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1997 - 2025
IL State Medical License 1991 - 2002
GA State Medical License 1997 - 1997- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Super Doctor SuperDoctors.com
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Nonmyeloablative Allogeneic Transplant Start of enrollment: 2001 Oct 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 48 citationsTransplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.Marcelo C. Pasquini, Júlio César Voltarelli, Harold L. Atkins, Nelson Hamerschlak, Xiaobo Zhong
Biology of Blood and Marrow Transplantation. 2012-10-01 - 90 citationsPhase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non–Hodgkin's LymphomaJohn P. Leonard, Brian K. Link, Christos Emmanouilides, Stephanie A. Gregory, Daniel J. Weisdorf
Clinical Cancer Research. 2007-10-15 - 4 citationsPurification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.Florent M. Martin, Josef T. Prchal, Jorge Nieva, Alan Saven, Jeffrey Andrey
British Journal of Haematology. 2008-11-01
Press Mentions
Jeffrey Andrey, M.D. Joins the Oncology Institute of Hope and InnovationJune 5th, 2019
Professional Memberships
- Member
Hospital Affiliations
Naval Medical Center San DiegoSan Diego, California
Scripps Green HospitalLa Jolla, California
Scripps Memorial Hospital-La JollaLa Jolla, California
